Cases

C3.ai, Inc. (NYSE: AI)

C3.AI INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of C3.ai, Inc. – AI

Magellan Midstream Partners, L.P. (NYSE: MMP)

MAGELLAN MIDSTREAM INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Magellan Midstream Partners, L.P. – MMP

Icahn Enterprises L.P. (NasdaqGS: IEP)

ICAHN ENTERPRISES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Icahn Enterprises L.P. – IEP

Beyond Meat, Inc. (NasdaqGS: BYND)

BEYOND MEAT SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Beyond Meat, Inc. – BYND

Western Digital Corporation (NasdaqGS: WDC)

WESTERN DIGITAL INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Western Digital Corporation – WDC

Home Point Capital Inc. (NasdaqGS: HMPT)

HOME POINT CAPITAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Home Point Capital Inc. – HMPT

Livent Corporation (NYSE: LTHM)

LIVENT CORPORATION INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of Livent Corporation – LTHM

Franchise Group, Inc. (NasdaqGM: FRG)

FRANCHISE GROUP INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Franchise Group, Inc. – FRG

CTI BioPharma Corp. (NasdaqCM: CTIC)

CTI BIOPHARMA INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CTI BioPharma Corp. – CTIC

Arconic Corporation (NYSE: ARNC)

ARCONIC INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arconic Corporation – ARNC

Amedisys, Inc. (NasdaqGS: AMED)

AMEDISYS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Amedisys, Inc. – AMED

IVERIC bio, Inc. (NasdaqGS: ISEE)

IVERIC BIO INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of IVERIC bio, Inc. – ISEE

Midwest Holding Inc. (NasdaqCM: MDWT)

MIDWEST HOLDING INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Midwest Holding Inc. – MDWT

Medical Properties Trust, Inc. (NYSE: MPW)

MEDICAL PROPERTIES TRUST INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Medical Properties Trust, Inc. – MPW

Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI)

SPECTRUM PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Spectrum Pharmaceuticals, Inc. – SPPI

LivePerson, Inc. (NasdaqGS: LPSN)

LIVEPERSON SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against LivePerson, Inc. – LPSN

Charah Solutions, Inc. (OTC: CHRA)

CHARAH SOLUTIONS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Charah Solutions, Inc. – CHRA

Prometheus Biosciences, Inc. (NasdaqGS: RXDX)

PROMETHEUS BIOSCIENCES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Prometheus Biosciences, Inc. – RXDX

Satsuma Pharmaceuticals, Inc. (NasdaqGM: STSA)

SATSUMA PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Satsuma Pharmaceuticals, Inc. – STSA